Sedative choice in pediatric intensive care may influence long-term neurocognitive outcomes
Penn Nursing researchers found that certain sedatives can affect long-term neurocognitive outcomes when used during critical illness early in childhood.
2 min. read
A new Penn Nursing study suggests that the specific sedatives used during critical illness in early childhood may have long-term implications for a child’s neurocognitive development. Martha A.Q. Curley, professor in the Department of Family and Community Health, and the Ruth M. Colket Endowed Chair in Pediatric Nursing at Children’s Hospital of Philadelphia, is a co-leader of the study.
The research, published in JAMA Network Open, finds that while most children who survived a critical illness requiring sedation had IQ scores within the normal range, those treated with a combination of only opioids and benzodiazepines score lower on later neurocognitive tests than those whose treatment include the sedative dexmedetomidine.
“For a long time, we haven’t had clear evidence on which sedatives are best for critically ill children on ventilators,” says Curley. “Our study shows that the choice we make in the pediatric ICU can affect a child’s brain development years later. Specifically, adding dexmedetomidine to our treatment plan may help protect a child’s long-term thinking and learning skills better than using opioids and benzodiazepines alone.”
The study highlights the importance of long-term follow-up for PICU survivors to identify and support children who may experience subtle but impactful neurocognitive challenges.
When the Schuylkill swallowed the city: Lessons from Hurricane Ida’s historic flood
New Penn research shows that Hurricane Ida wasn’t a once-in-a-century anomaly but a preview of how climate change, urbanization, and aging infrastructure are rewriting flood risk.
The Fed explained: What it does and why it matters
Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy
How population changes are impacting primary education worldwide
Research from Penn sociologist Emily Hannum and colleagues reveals regional trends in whether school-age populations are increasing, plateauing, or decreasing—and shows how different countries are responding.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
